Preprocedural hemoglobin predicts mortality following peripheral vascular interventions

Catheterization and Cardiovascular Interventions

Volumn 78, Issue 4, 2011, Pages 599-603

  Jaffery, Zehra ^a   Shamai, Lior ^a   White, Christopher J ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

hemoglobin; mortality; peripheral vascular interventions; predictors

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; ENDOVASCULAR PROCEDURES; FEMALE; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; LOUISIANA; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053191563     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23065     Document Type: Article

References (14)

1. Reinecke H, Trey T, Wellmann J, et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003; 24: 2142-2150. (Pubitemid 37486534)
2. Lee KH, Lee SR, Kang KP, et al. Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients. Korean Circ J 2010; 40: 68-73.
3. Sattur S, Harjai KJ, Narula A, et al. The influence of anemia after percutaneous coronary intervention on clinical outcomes. Clin Cardiol 2009; 32: 373-379.
4. Toor IS, Jaumdally RJ, Moss MS, et al. Preprocedural hemoglobin predicts outcome in peripheral vascular disease patients undergoing percutaneous transluminal angioplasty. J Vasc Surg 2009; 50: 317-321.
5. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993; 329: 673-682.
6. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-2268. (Pubitemid 39331821)
7. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27-33. (Pubitemid 34701373)
8. Most AS, Ruocco NA Jr, Gewirtz H,. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 1986; 74: 1085-1092. (Pubitemid 17174957)
9. Levy PS, Kim SJ, Eckel PK, et al. Limit to cardiac compensation during acute isovolemic hemodilution: Influence of coronary stenosis. Am J Physiol 1993; 265 (1 Pt 2): H340-349. (Pubitemid 23224729)
10. Gagnon DR, Zhang TJ, Brand FN, et al. Hematocrit and the risk of cardiovascular disease-the Framingham study: A 34-year follow-up. Am Heart J 1994; 127: 674-682. (Pubitemid 24124700)
11. Lowe GD, Forbes CD,. Blood rheology and thrombosis. Clin Haematol 1981; 10: 343-367.
12. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049. (Pubitemid 40577898)
13. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY Trial. J Am Coll Cardiol 2007; 49: 1362-1368. (Pubitemid 46476844)
14. Singh M, Holmes DR, Lennon RJ, et al. Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions. Circ Cardiovasc Interv 2010; 3: 423-430.